Patrick H Maxwell Selected Research

oxalylglycine

7/2011	Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells.
11/2009	Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors.
1/2008	Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick H Maxwell Research Topics

Disease

60	Hypoxia (Hypoxemia) 03/2022 - 01/2002
22	Neoplasms (Cancer) 01/2019 - 02/2002
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 05/2002
8	Anemia 03/2010 - 07/2002
6	Ischemia 04/2012 - 07/2002
5	Polycythemia (Erythrocytosis) 04/2017 - 12/2002
5	IGA Glomerulonephritis (IGA Nephropathy) 02/2013 - 07/2004
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 04/2006
4	Inflammation (Inflammations) 09/2017 - 12/2008
4	Kidney Diseases (Kidney Disease) 01/2017 - 05/2009
3	Genomic Instability 05/2016 - 12/2011
3	Carcinoma (Carcinomatosis) 04/2016 - 04/2008
3	Reperfusion Injury 10/2014 - 01/2008
3	Glomerulonephritis 02/2013 - 09/2010
2	Cysts 11/2016 - 10/2011
2	Myocardial Infarction 10/2014 - 07/2006
2	Neoplasm Metastasis (Metastasis) 05/2013 - 12/2010
2	Acute Kidney Injury (Acute Renal Failure) 11/2011 - 04/2009
2	Carcinogenesis 10/2011 - 11/2010
2	Renal Insufficiency (Renal Failure) 09/2010 - 05/2009
1	COVID-19 03/2022
1	Fibrosis (Cirrhosis) 01/2019
1	MASS syndrome 01/2018
1	Hepatitis B 01/2017
1	Vitamin D Deficiency 01/2017
1	Tyrosinemias (Tyrosinemia) 01/2017
1	Hepatic Insufficiency 01/2017
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2016
1	Muscle Cramp (Cramp) 11/2016
1	Rickets (Rachitis) 01/2016
1	Cicatrix (Scar) 10/2014

Drug/Important Bio-Agent (IBA)

28	Oxygen (Dioxygen)IBA 01/2021 - 06/2002
22	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2002
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2002
11	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2018 - 01/2004
11	Erythropoietin FDA Link 04/2017 - 07/2002
10	EnzymesIBA 10/2017 - 01/2004
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 02/2002
5	Messenger RNA (mRNA)IBA 03/2022 - 09/2004
4	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 07/2009
4	UbiquitinIBA 06/2013 - 05/2002
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2006 - 01/2002
3	Mixed Function Oxygenases (Monooxygenases)IBA 10/2017 - 01/2008
3	Protein Isoforms (Isoforms)IBA 04/2017 - 07/2005
3	Complement System Proteins (Complement)IBA 02/2013 - 01/2006
3	Retinaldehyde (Retinal)IBA 07/2012 - 06/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 02/2002
3	Fumarate Hydratase (Fumarase)IBA 10/2011 - 11/2010
3	oxalylglycineIBA 07/2011 - 01/2008
3	HepcidinsIBA 03/2010 - 05/2009
3	IronIBA 03/2010 - 05/2009
2	RNA (Ribonucleic Acid)IBA 03/2022 - 07/2009
2	CollagenIBA 01/2019 - 10/2017
2	Ligases (Synthetase)IBA 01/2018 - 06/2002
2	Prolyl-Hydroxylase InhibitorsIBA 09/2017 - 12/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2016 - 06/2013
2	Arginine (L-Arginine)FDA Link 03/2016 - 12/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016 - 01/2006
2	Retroelements (Retrotransposon)IBA 10/2015 - 12/2011
2	Immunoglobulins (Immunoglobulin)IBA 02/2013 - 05/2010
2	AntioxidantsIBA 02/2012 - 10/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2011 - 11/2010
2	FumaratesIBA 10/2011 - 11/2010
2	MimosineIBA 12/2010 - 01/2008
2	Hypoxia-Inducible Factor 1IBA 12/2010 - 07/2005
2	Pharmaceutical PreparationsIBA 06/2010 - 05/2010
2	Hormones (Hormone)IBA 03/2010 - 02/2008
2	Carbon MonoxideIBA 11/2009 - 07/2002
2	Small Interfering RNA (siRNA)IBA 04/2009 - 08/2005
2	Cadherins (E-Cadherin)IBA 02/2009 - 04/2006
2	3' Untranslated Regions (3' UTR)IBA 06/2006 - 07/2004
1	Factor V (Coagulation Factor V)IBA 03/2022
1	ChromatinIBA 01/2021
1	Histone MethyltransferasesIBA 01/2021
1	endothelial PAS domain-containing protein 1IBA 01/2021
1	Complement C1q (C1q Complement)IBA 10/2017
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	fumarylacetoacetateIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	LipidsIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Collagen Type IV (Type IV Collagen)IBA 11/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2016
1	ADI PEG20IBA 03/2016
1	CalciumIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 10/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2014
1	Mitochondrial Permeability Transition PoreIBA 10/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2014
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	p38 Mitogen-Activated Protein KinasesIBA 06/2013
1	Deubiquitinating EnzymesIBA 06/2013

Therapy/Procedure

3	Therapeutics 03/2016 - 04/2009
2	Ligation 07/2006 - 09/2004
1	Homologous Transplantation 01/2017
1	Transplantation 04/2016
1	Molecular Targeted Therapy 10/2013